National socioeconomic indicators are associated with outcomes after aneurysmal subarachnoid hemorrhage: A hierarchical mixed-effects analysis: Clinical article

Journal of Neurosurgery

Volumn 121, Issue 5, 2014, Pages 1039-1047

  Guha, Daipayan ^a   Ibrahim, George M ^a   Kertzer, Joshua D ^b   MacDonald, R Loch ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Random effects analysis; Socioeconomic indicators; Subarachnoid hemorrhage; Tirilazad; Vascular disorders

Indexed keywords

PLACEBO; TIRILAZAD; NEUROPROTECTIVE AGENT; PREGNANE DERIVATIVE;

ADULT; ARTICLE; BLINDNESS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; DATA BASE; FEMALE; GLASGOW OUTCOME SCALE; GROSS NATIONAL PRODUCT; HUMAN; HYDROCEPHALUS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; SOCIOECONOMICS; SUBARACHNOID HEMORRHAGE; VASOSPASM; ALGORITHM; ANEURYSM, RUPTURED; ECONOMICS; NEUROSURGERY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ALGORITHMS; ANEURYSM, RUPTURED; DATA INTERPRETATION, STATISTICAL; FEMALE; GLASGOW OUTCOME SCALE; GROSS DOMESTIC PRODUCT; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROSURGERY; PREGNATRIENES; SOCIOECONOMIC FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84922393455     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.7.JNS132141     Document Type: Article

References (40)

1. ACROSS Group: Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 31:1843-1850, 2000
2. Bardach NS, Zhao S, Gress DR, Lawton MT, Johnston SC: Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke 33: 1851-1856, 2002
3. Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D: Comparative performance of private and public healthcare systems in low-and middle-income countries: a systematic review. PLoS Med 9:e1001244, 2012
4. Berendes S, Heywood P, Oliver S, Garner P: Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies. PLoS Med 8:e1000433, 2011
5. Berg TO: The birth of neurosurgery as a specialty in Norway. (http://www.ous-research.no/home/langmoen/Neurosur gery%20in%20Norway?submenu=1) [Accessed July 6, 2014]
6. Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP: Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34:2200-2207, 2003
7. Bertalanffy H, Koechlin N: Practicing neurosurgery in Switzerland. AANS Neurosurgeon 17(3):15, 2008
8. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A: Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25:1342-1347, 1994
9. de Andrade L, Zanini V, Batilana AP, de Carvalho EC, Pietrobon R, Nihei OK, et al: Regional disparities in mortality after ischemic heart disease in a Brazilian state from 2006 to 2010. PLoS ONE 8:e59363, 2013
10. Drake CG, Hunt WE, Sano K, Kassell N, Teasdale G, Pertuiset B, et al: Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986, 1988 (Letter)
11. Fogelholm R, Hernesniemi J, Vapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 24:1649-1654, 1993
12. Gjerris F, Madsen FF: How many neurosurgeons do we want to educate in Europe annually? The Danish proposal. Acta Neurochir Suppl 69:40-42, 1997
13. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995
14. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467-474, 1997
15. Helbok R, Kurtz P, Vibbert M, Schmidt MJ, Fernandez L, Lantigua H, et al: Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome. J Neurol Neurosurg Psychiatry 84:266-270, 2013
16. Hoh BL, Rabinov JD, Pryor JC, Carter BS, Barker FG II: Inhospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume. AJNR Am J Neuroradiol 24:1409-1420, 2003
17. Hugenholtz H: Neurosurgery workforce in Canada, 1996 to 2011. CMAJ 155:39-48, 1996
18. Ibrahim GM, Fallah A, Macdonald RL: Clinical, laboratory, and radiographic predictors of the occurrence of seizures following aneurysmal subarachnoid hemorrhage. Clinical article. J Neurosurg 119:347-352, 2013
19. Ingall T, Asplund K, Mähönen M, Bonita R: A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 31:1054-1061, 2000
20. Jaja BN, Saposnik G, Nisenbaum R, Schweizer TA, Reddy D, Thorpe KE, et al: Effect of socioeconomic status on inpatient mortality and use of postacute care after subarachnoid hemorrhage. Stroke 44:2842-2847, 2013
21. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996
22. Kertzer JD: Making sense of isolationism: foreign policy mood as a multilevel phenomenon. J Polit 75:225-240, 2013
23. Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, et al: Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 33:200-208, 2002
24. Lanzino G, Kassell NF: Double-blind, randomized, vehiclecontrolled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-1024, 1999
25. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, et al: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-1017, 1999
26. Larsen K, Merlo J: Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 161: 81-88, 2005
27. Larsen K, Petersen JH, Budtz-Jørgensen E, Endahl L: Interpreting parameters in the logistic regression model with random effects. Biometrics 56:909-914, 2000
28. Lipsman N, Tolentino J, Macdonald RL: Effect of country or continent of treatment on outcome after aneurysmal subarachnoid hemorrhage. Clinical article. J Neurosurg 111:67-74, 2009
29. Mastronardi L: Practicing neurosurgery in Italy. AANS Neurosurgeon 17(3):12-13, 2008
30. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267-1274, 2002
31. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ: Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635-642, 2009
32. Nuño M, Mukherjee D, Carico C, Elramsisy A, Veeravagu A, Black KL, et al: The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001-2007. Acta Neurochir (Wien) 154:1343-1350, 2012
33. Rabe-Hesketh S, Skrondal A, Pickles A: Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J 2:1-21, 2002
34. Reulen HJ, Hide RAB, Bettag M, Bodosi M, Cunha e Sa M: A report on neurosurgical workforce in the countries of the EU and associated states. Task Force Workforce Planning, UEMS Section of Neurosurgery. Acta Neurochir (Wien) 151:715-721, 2009
35. Ropper AH, Zervas NT: Outcome 1 year after SAH from cerebral aneurysm. Management morbidity, mortality, and functional status in 112 consecutive good-risk patients. J Neurosurg 60:909-915, 1984
36. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL: Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315-2321, 2007
37. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420-428, 1979
38. Spetzler RF, McDougall CG, Albuquerque FC, Zabramski JM, Hills NK, Partovi S, et al: The Barrow Ruptured Aneurysm Trial: 3-year results. Clinical article. J Neurosurg 119: 146-157, 2013
39. Sposato LA, Saposnik G: Gross domestic product and health expenditure associated with incidence, 30-day fatality, and age at stroke onset: a systematic review. Stroke 43:170-177, 2012
40. Van Calenbergh F, Van den Bergh R: The Belgian Society for Neurosurgery. Acta Neurochir (Wien) 147:1305-1307, 2005